nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—DHCR7—Epirubicin—pancreatic cancer	0.173	0.24	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—pancreatic cancer	0.0918	0.127	CbGbCtD
Tamoxifen—CES1—Irinotecan—pancreatic cancer	0.0464	0.0644	CbGbCtD
Tamoxifen—CYP1B1—Erlotinib—pancreatic cancer	0.0295	0.0409	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—pancreatic cancer	0.0195	0.0271	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—pancreatic cancer	0.0191	0.0266	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—pancreatic cancer	0.0148	0.0205	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—pancreatic cancer	0.0146	0.0202	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—pancreatic cancer	0.0146	0.0202	CbGbCtD
Tamoxifen—ABCG2—Erlotinib—pancreatic cancer	0.014	0.0195	CbGbCtD
Tamoxifen—ABCC2—Irinotecan—pancreatic cancer	0.014	0.0194	CbGbCtD
Tamoxifen—CYP2A6—Fluorouracil—pancreatic cancer	0.0131	0.0182	CbGbCtD
Tamoxifen—CYP1A1—Erlotinib—pancreatic cancer	0.0129	0.018	CbGbCtD
Tamoxifen—ABCG2—Irinotecan—pancreatic cancer	0.0127	0.0176	CbGbCtD
Tamoxifen—ABCG2—Fluorouracil—pancreatic cancer	0.0122	0.0169	CbGbCtD
Tamoxifen—ABCB11—bile duct—pancreatic cancer	0.0107	0.21	CbGeAlD
Tamoxifen—ABCC2—Docetaxel—pancreatic cancer	0.0103	0.0142	CbGbCtD
Tamoxifen—ABCC2—Sunitinib—pancreatic cancer	0.0102	0.0142	CbGbCtD
Tamoxifen—CYP3A7—Irinotecan—pancreatic cancer	0.00935	0.013	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.00935	0.013	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—pancreatic cancer	0.00928	0.0129	CbGbCtD
Tamoxifen—ABCG2—Sunitinib—pancreatic cancer	0.00924	0.0128	CbGbCtD
Tamoxifen—CYP2B6—Irinotecan—pancreatic cancer	0.00891	0.0124	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—pancreatic cancer	0.00855	0.0119	CbGbCtD
Tamoxifen—ABCB11—bile—pancreatic cancer	0.00821	0.161	CbGeAlD
Tamoxifen—CYP3A5—Erlotinib—pancreatic cancer	0.00777	0.0108	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—pancreatic cancer	0.00765	0.0106	CbGbCtD
Tamoxifen—CYP2C8—Erlotinib—pancreatic cancer	0.00747	0.0104	CbGbCtD
Tamoxifen—CYP3A5—Irinotecan—pancreatic cancer	0.00702	0.00974	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—pancreatic cancer	0.00692	0.0096	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—pancreatic cancer	0.00686	0.00951	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00686	0.00951	CbGbCtD
Tamoxifen—CYP3A7—Sunitinib—pancreatic cancer	0.00682	0.00947	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00682	0.00947	CbGbCtD
Tamoxifen—CYP2C8—Fluorouracil—pancreatic cancer	0.00647	0.00898	CbGbCtD
Tamoxifen—CYP1A2—Erlotinib—pancreatic cancer	0.00578	0.00802	CbGbCtD
Tamoxifen—ABCC2—bile duct—pancreatic cancer	0.00543	0.107	CbGeAlD
Tamoxifen—CYP3A5—Docetaxel—pancreatic cancer	0.00514	0.00714	CbGbCtD
Tamoxifen—ABCB1—Gemcitabine—pancreatic cancer	0.00512	0.00711	CbGbCtD
Tamoxifen—CYP3A5—Sunitinib—pancreatic cancer	0.00512	0.0071	CbGbCtD
Tamoxifen—ABCB1—Erlotinib—pancreatic cancer	0.00506	0.00702	CbGbCtD
Tamoxifen—CYP1A2—Fluorouracil—pancreatic cancer	0.00501	0.00695	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—pancreatic cancer	0.00487	0.00675	CbGbCtD
Tamoxifen—CYP2D6—Erlotinib—pancreatic cancer	0.00476	0.00661	CbGbCtD
Tamoxifen—ABCB1—Irinotecan—pancreatic cancer	0.00457	0.00634	CbGbCtD
Tamoxifen—CYP2C9—Fluorouracil—pancreatic cancer	0.00452	0.00627	CbGbCtD
Tamoxifen—ABCC2—bile—pancreatic cancer	0.00417	0.0821	CbGeAlD
Tamoxifen—ABCB1—Docetaxel—pancreatic cancer	0.00335	0.00464	CbGbCtD
Tamoxifen—ABCB1—Sunitinib—pancreatic cancer	0.00333	0.00462	CbGbCtD
Tamoxifen—CYP3A4—Erlotinib—pancreatic cancer	0.00303	0.0042	CbGbCtD
Tamoxifen—CYP3A4—Irinotecan—pancreatic cancer	0.00274	0.0038	CbGbCtD
Tamoxifen—ABCB1—Doxorubicin—pancreatic cancer	0.00249	0.00346	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—pancreatic cancer	0.00235	0.00326	CbGbCtD
Tamoxifen—CYP3A4—Docetaxel—pancreatic cancer	0.00201	0.00278	CbGbCtD
Tamoxifen—CYP3A4—Sunitinib—pancreatic cancer	0.002	0.00277	CbGbCtD
Tamoxifen—CES1—gall bladder—pancreatic cancer	0.00178	0.035	CbGeAlD
Tamoxifen—DHCR7—islet of Langerhans—pancreatic cancer	0.00171	0.0336	CbGeAlD
Tamoxifen—ESRRA—islet of Langerhans—pancreatic cancer	0.00168	0.0331	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—pancreatic cancer	0.00149	0.00207	CbGbCtD
Tamoxifen—SULT1A1—digestive system—pancreatic cancer	0.00144	0.0284	CbGeAlD
Tamoxifen—UGT1A4—digestive system—pancreatic cancer	0.00126	0.0247	CbGeAlD
Tamoxifen—DHCR7—pancreas—pancreatic cancer	0.0012	0.0236	CbGeAlD
Tamoxifen—ESRRA—pancreas—pancreatic cancer	0.00118	0.0232	CbGeAlD
Tamoxifen—DHCR7—digestive system—pancreatic cancer	0.00103	0.0202	CbGeAlD
Tamoxifen—FMO1—digestive system—pancreatic cancer	0.00103	0.0202	CbGeAlD
Tamoxifen—ESRRA—digestive system—pancreatic cancer	0.00101	0.0199	CbGeAlD
Tamoxifen—ABCB11—digestive system—pancreatic cancer	0.000897	0.0176	CbGeAlD
Tamoxifen—EBP—Azacitidine—Gemcitabine—pancreatic cancer	0.000825	1	CbGdCrCtD
Tamoxifen—SIGMAR1—islet of Langerhans—pancreatic cancer	0.000782	0.0154	CbGeAlD
Tamoxifen—CES1—digestive system—pancreatic cancer	0.0007	0.0138	CbGeAlD
Tamoxifen—ESR2—digestive system—pancreatic cancer	0.000606	0.0119	CbGeAlD
Tamoxifen—SIGMAR1—pancreas—pancreatic cancer	0.00055	0.0108	CbGeAlD
Tamoxifen—CYP3A5—islet of Langerhans—pancreatic cancer	0.000514	0.0101	CbGeAlD
Tamoxifen—ABCC2—digestive system—pancreatic cancer	0.000456	0.00896	CbGeAlD
Tamoxifen—CYP1B1—digestive system—pancreatic cancer	0.000446	0.00878	CbGeAlD
Tamoxifen—ESR1—digestive system—pancreatic cancer	0.000415	0.00816	CbGeAlD
Tamoxifen—CYP2C19—digestive system—pancreatic cancer	0.000392	0.0077	CbGeAlD
Tamoxifen—CYP3A5—pancreas—pancreatic cancer	0.000361	0.0071	CbGeAlD
Tamoxifen—CYP1A2—digestive system—pancreatic cancer	0.00032	0.00629	CbGeAlD
Tamoxifen—CYP1A1—digestive system—pancreatic cancer	0.000316	0.00621	CbGeAlD
Tamoxifen—CYP3A5—digestive system—pancreatic cancer	0.000309	0.00607	CbGeAlD
Tamoxifen—CYP2B6—digestive system—pancreatic cancer	0.000307	0.00603	CbGeAlD
Tamoxifen—CYP2C9—digestive system—pancreatic cancer	0.000304	0.00597	CbGeAlD
Tamoxifen—CYP2E1—digestive system—pancreatic cancer	0.000288	0.00566	CbGeAlD
Tamoxifen—ABCB1—islet of Langerhans—pancreatic cancer	0.000273	0.00537	CbGeAlD
Tamoxifen—CYP3A4—digestive system—pancreatic cancer	0.000232	0.00455	CbGeAlD
Tamoxifen—CYP2D6—digestive system—pancreatic cancer	0.000228	0.00448	CbGeAlD
Tamoxifen—ABCB1—pancreas—pancreatic cancer	0.000192	0.00377	CbGeAlD
Tamoxifen—ABCB1—digestive system—pancreatic cancer	0.000164	0.00322	CbGeAlD
Tamoxifen—Dyspnoea—Irinotecan—pancreatic cancer	0.000111	0.000667	CcSEcCtD
Tamoxifen—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000111	0.000665	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000111	0.000664	CcSEcCtD
Tamoxifen—Rash—Erlotinib—pancreatic cancer	0.000111	0.000661	CcSEcCtD
Tamoxifen—Dermatitis—Erlotinib—pancreatic cancer	0.00011	0.000661	CcSEcCtD
Tamoxifen—Insomnia—Gemcitabine—pancreatic cancer	0.00011	0.000659	CcSEcCtD
Tamoxifen—Dyspepsia—Irinotecan—pancreatic cancer	0.00011	0.000658	CcSEcCtD
Tamoxifen—Headache—Erlotinib—pancreatic cancer	0.00011	0.000657	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—pancreatic cancer	0.00011	0.000657	CcSEcCtD
Tamoxifen—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00011	0.000655	CcSEcCtD
Tamoxifen—Paraesthesia—Gemcitabine—pancreatic cancer	0.000109	0.000654	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000109	0.000653	CcSEcCtD
Tamoxifen—Asthenia—Sunitinib—pancreatic cancer	0.000109	0.000652	CcSEcCtD
Tamoxifen—Decreased appetite—Irinotecan—pancreatic cancer	0.000109	0.00065	CcSEcCtD
Tamoxifen—Arrhythmia—Docetaxel—pancreatic cancer	0.000109	0.00065	CcSEcCtD
Tamoxifen—Dyspnoea—Gemcitabine—pancreatic cancer	0.000109	0.00065	CcSEcCtD
Tamoxifen—Insomnia—Fluorouracil—pancreatic cancer	0.000108	0.000648	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000108	0.000646	CcSEcCtD
Tamoxifen—Fatigue—Irinotecan—pancreatic cancer	0.000108	0.000645	CcSEcCtD
Tamoxifen—Paraesthesia—Fluorouracil—pancreatic cancer	0.000108	0.000643	CcSEcCtD
Tamoxifen—Alopecia—Docetaxel—pancreatic cancer	0.000108	0.000643	CcSEcCtD
Tamoxifen—Pruritus—Sunitinib—pancreatic cancer	0.000107	0.000642	CcSEcCtD
Tamoxifen—Pain—Irinotecan—pancreatic cancer	0.000107	0.00064	CcSEcCtD
Tamoxifen—Constipation—Irinotecan—pancreatic cancer	0.000107	0.00064	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000107	0.000639	CcSEcCtD
Tamoxifen—Dyspnoea—Fluorouracil—pancreatic cancer	0.000107	0.000639	CcSEcCtD
Tamoxifen—Erythema—Docetaxel—pancreatic cancer	0.000106	0.000634	CcSEcCtD
Tamoxifen—Decreased appetite—Gemcitabine—pancreatic cancer	0.000106	0.000633	CcSEcCtD
Tamoxifen—Dyspepsia—Fluorouracil—pancreatic cancer	0.000105	0.000631	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000105	0.000629	CcSEcCtD
Tamoxifen—Fatigue—Gemcitabine—pancreatic cancer	0.000105	0.000628	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000105	0.000626	CcSEcCtD
Tamoxifen—Constipation—Gemcitabine—pancreatic cancer	0.000104	0.000623	CcSEcCtD
Tamoxifen—Pain—Gemcitabine—pancreatic cancer	0.000104	0.000623	CcSEcCtD
Tamoxifen—Nausea—Erlotinib—pancreatic cancer	0.000104	0.000623	CcSEcCtD
Tamoxifen—Decreased appetite—Fluorouracil—pancreatic cancer	0.000104	0.000623	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—pancreatic cancer	0.000104	0.000622	CcSEcCtD
Tamoxifen—Diarrhoea—Sunitinib—pancreatic cancer	0.000104	0.000621	CcSEcCtD
Tamoxifen—Dysgeusia—Docetaxel—pancreatic cancer	0.000104	0.00062	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000103	0.000618	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000103	0.000615	CcSEcCtD
Tamoxifen—Dysphagia—Epirubicin—pancreatic cancer	0.000103	0.000613	CcSEcCtD
Tamoxifen—Influenza—Epirubicin—pancreatic cancer	0.000103	0.000613	CcSEcCtD
Tamoxifen—Back pain—Docetaxel—pancreatic cancer	0.000102	0.000613	CcSEcCtD
Tamoxifen—Pain—Fluorouracil—pancreatic cancer	0.000102	0.000613	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000102	0.000612	CcSEcCtD
Tamoxifen—Muscle spasms—Docetaxel—pancreatic cancer	0.000102	0.000609	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000606	CcSEcCtD
Tamoxifen—Pancreatitis—Epirubicin—pancreatic cancer	0.000101	0.000601	CcSEcCtD
Tamoxifen—Dizziness—Sunitinib—pancreatic cancer	0.0001	0.0006	CcSEcCtD
Tamoxifen—Angina pectoris—Epirubicin—pancreatic cancer	9.99e-05	0.000597	CcSEcCtD
Tamoxifen—Abdominal pain—Irinotecan—pancreatic cancer	9.88e-05	0.000591	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	9.88e-05	0.000591	CcSEcCtD
Tamoxifen—Bronchitis—Epirubicin—pancreatic cancer	9.86e-05	0.00059	CcSEcCtD
Tamoxifen—Anaemia—Docetaxel—pancreatic cancer	9.79e-05	0.000586	CcSEcCtD
Tamoxifen—Pancytopenia—Epirubicin—pancreatic cancer	9.74e-05	0.000582	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	9.68e-05	0.000579	CcSEcCtD
Tamoxifen—Vomiting—Sunitinib—pancreatic cancer	9.65e-05	0.000577	CcSEcCtD
Tamoxifen—Neutropenia—Epirubicin—pancreatic cancer	9.59e-05	0.000573	CcSEcCtD
Tamoxifen—Rash—Sunitinib—pancreatic cancer	9.57e-05	0.000573	CcSEcCtD
Tamoxifen—Dermatitis—Sunitinib—pancreatic cancer	9.56e-05	0.000572	CcSEcCtD
Tamoxifen—Urticaria—Fluorouracil—pancreatic cancer	9.51e-05	0.000569	CcSEcCtD
Tamoxifen—Headache—Sunitinib—pancreatic cancer	9.51e-05	0.000569	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—pancreatic cancer	9.49e-05	0.000567	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—pancreatic cancer	9.49e-05	0.000567	CcSEcCtD
Tamoxifen—Leukopenia—Docetaxel—pancreatic cancer	9.48e-05	0.000567	CcSEcCtD
Tamoxifen—Weight increased—Epirubicin—pancreatic cancer	9.33e-05	0.000558	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—pancreatic cancer	9.3e-05	0.000556	CcSEcCtD
Tamoxifen—Weight decreased—Epirubicin—pancreatic cancer	9.28e-05	0.000555	CcSEcCtD
Tamoxifen—Cough—Docetaxel—pancreatic cancer	9.24e-05	0.000553	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—pancreatic cancer	9.24e-05	0.000553	CcSEcCtD
Tamoxifen—Hypersensitivity—Irinotecan—pancreatic cancer	9.21e-05	0.000551	CcSEcCtD
Tamoxifen—Pneumonia—Epirubicin—pancreatic cancer	9.19e-05	0.00055	CcSEcCtD
Tamoxifen—Hypertension—Docetaxel—pancreatic cancer	9.14e-05	0.000547	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—pancreatic cancer	9.12e-05	0.000546	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	9.06e-05	0.000542	CcSEcCtD
Tamoxifen—Chest pain—Docetaxel—pancreatic cancer	9.02e-05	0.000539	CcSEcCtD
Tamoxifen—Arthralgia—Docetaxel—pancreatic cancer	9.02e-05	0.000539	CcSEcCtD
Tamoxifen—Myalgia—Docetaxel—pancreatic cancer	9.02e-05	0.000539	CcSEcCtD
Tamoxifen—Nausea—Sunitinib—pancreatic cancer	9.02e-05	0.000539	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—pancreatic cancer	9.01e-05	0.000539	CcSEcCtD
Tamoxifen—Asthenia—Irinotecan—pancreatic cancer	8.97e-05	0.000537	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—pancreatic cancer	8.89e-05	0.000532	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—pancreatic cancer	8.87e-05	0.000531	CcSEcCtD
Tamoxifen—Hypersensitivity—Fluorouracil—pancreatic cancer	8.82e-05	0.000528	CcSEcCtD
Tamoxifen—Dry mouth—Docetaxel—pancreatic cancer	8.82e-05	0.000528	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—pancreatic cancer	8.76e-05	0.000524	CcSEcCtD
Tamoxifen—Asthenia—Gemcitabine—pancreatic cancer	8.74e-05	0.000523	CcSEcCtD
Tamoxifen—Oedema—Docetaxel—pancreatic cancer	8.64e-05	0.000517	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—pancreatic cancer	8.63e-05	0.000516	CcSEcCtD
Tamoxifen—Pruritus—Gemcitabine—pancreatic cancer	8.62e-05	0.000515	CcSEcCtD
Tamoxifen—Infection—Docetaxel—pancreatic cancer	8.59e-05	0.000514	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—pancreatic cancer	8.58e-05	0.000513	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—pancreatic cancer	8.58e-05	0.000513	CcSEcCtD
Tamoxifen—Diarrhoea—Irinotecan—pancreatic cancer	8.56e-05	0.000512	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—pancreatic cancer	8.51e-05	0.000509	CcSEcCtD
Tamoxifen—Pruritus—Fluorouracil—pancreatic cancer	8.47e-05	0.000507	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—pancreatic cancer	8.46e-05	0.000506	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.39e-05	0.000502	CcSEcCtD
Tamoxifen—Diarrhoea—Gemcitabine—pancreatic cancer	8.33e-05	0.000499	CcSEcCtD
Tamoxifen—Dizziness—Irinotecan—pancreatic cancer	8.27e-05	0.000495	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—pancreatic cancer	8.25e-05	0.000493	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—pancreatic cancer	8.24e-05	0.000493	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—pancreatic cancer	8.22e-05	0.000492	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—pancreatic cancer	8.21e-05	0.000491	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—pancreatic cancer	8.21e-05	0.000491	CcSEcCtD
Tamoxifen—Diarrhoea—Fluorouracil—pancreatic cancer	8.19e-05	0.00049	CcSEcCtD
Tamoxifen—Hypoaesthesia—Epirubicin—pancreatic cancer	8.16e-05	0.000488	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—pancreatic cancer	8.14e-05	0.000487	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—pancreatic cancer	8.11e-05	0.000485	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—pancreatic cancer	8.08e-05	0.000484	CcSEcCtD
Tamoxifen—Vomiting—Irinotecan—pancreatic cancer	7.95e-05	0.000476	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—pancreatic cancer	7.94e-05	0.000475	CcSEcCtD
Tamoxifen—Dizziness—Fluorouracil—pancreatic cancer	7.92e-05	0.000474	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—pancreatic cancer	7.91e-05	0.000473	CcSEcCtD
Tamoxifen—Rash—Irinotecan—pancreatic cancer	7.88e-05	0.000472	CcSEcCtD
Tamoxifen—Dermatitis—Irinotecan—pancreatic cancer	7.88e-05	0.000471	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.87e-05	0.000471	CcSEcCtD
Tamoxifen—Headache—Irinotecan—pancreatic cancer	7.83e-05	0.000469	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—pancreatic cancer	7.82e-05	0.000468	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—pancreatic cancer	7.76e-05	0.000464	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—pancreatic cancer	7.76e-05	0.000464	CcSEcCtD
Tamoxifen—Vomiting—Gemcitabine—pancreatic cancer	7.74e-05	0.000463	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—pancreatic cancer	7.71e-05	0.000461	CcSEcCtD
Tamoxifen—Rash—Gemcitabine—pancreatic cancer	7.68e-05	0.000459	CcSEcCtD
Tamoxifen—Dermatitis—Gemcitabine—pancreatic cancer	7.67e-05	0.000459	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—pancreatic cancer	7.63e-05	0.000457	CcSEcCtD
Tamoxifen—Headache—Gemcitabine—pancreatic cancer	7.63e-05	0.000456	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—pancreatic cancer	7.62e-05	0.000456	CcSEcCtD
Tamoxifen—Vomiting—Fluorouracil—pancreatic cancer	7.61e-05	0.000455	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—pancreatic cancer	7.61e-05	0.000455	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—pancreatic cancer	7.59e-05	0.000454	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—pancreatic cancer	7.59e-05	0.000454	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.55e-05	0.000452	CcSEcCtD
Tamoxifen—Rash—Fluorouracil—pancreatic cancer	7.55e-05	0.000452	CcSEcCtD
Tamoxifen—Dermatitis—Fluorouracil—pancreatic cancer	7.54e-05	0.000451	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—pancreatic cancer	7.54e-05	0.000451	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—pancreatic cancer	7.51e-05	0.000449	CcSEcCtD
Tamoxifen—Headache—Fluorouracil—pancreatic cancer	7.5e-05	0.000449	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—pancreatic cancer	7.48e-05	0.000447	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.46e-05	0.000446	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—pancreatic cancer	7.45e-05	0.000446	CcSEcCtD
Tamoxifen—Nausea—Irinotecan—pancreatic cancer	7.43e-05	0.000444	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—pancreatic cancer	7.39e-05	0.000442	CcSEcCtD
Tamoxifen—Pain—Docetaxel—pancreatic cancer	7.39e-05	0.000442	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—pancreatic cancer	7.33e-05	0.000439	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—pancreatic cancer	7.32e-05	0.000438	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—pancreatic cancer	7.25e-05	0.000434	CcSEcCtD
Tamoxifen—Nausea—Gemcitabine—pancreatic cancer	7.23e-05	0.000433	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—pancreatic cancer	7.18e-05	0.000429	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—pancreatic cancer	7.14e-05	0.000427	CcSEcCtD
Tamoxifen—Nausea—Fluorouracil—pancreatic cancer	7.11e-05	0.000426	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.07e-05	0.000423	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—pancreatic cancer	7.05e-05	0.000422	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—pancreatic cancer	7e-05	0.000418	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—pancreatic cancer	6.91e-05	0.000413	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—pancreatic cancer	6.87e-05	0.000411	CcSEcCtD
Tamoxifen—Abdominal pain—Docetaxel—pancreatic cancer	6.83e-05	0.000409	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—pancreatic cancer	6.78e-05	0.000406	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—pancreatic cancer	6.71e-05	0.000401	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—pancreatic cancer	6.61e-05	0.000395	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—pancreatic cancer	6.6e-05	0.000395	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—pancreatic cancer	6.47e-05	0.000387	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—pancreatic cancer	6.39e-05	0.000383	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—pancreatic cancer	6.39e-05	0.000382	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—pancreatic cancer	6.37e-05	0.000381	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—pancreatic cancer	6.35e-05	0.00038	CcSEcCtD
Tamoxifen—Cough—Epirubicin—pancreatic cancer	6.23e-05	0.000373	CcSEcCtD
Tamoxifen—Asthenia—Docetaxel—pancreatic cancer	6.2e-05	0.000371	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—pancreatic cancer	6.17e-05	0.000369	CcSEcCtD
Tamoxifen—Pruritus—Docetaxel—pancreatic cancer	6.12e-05	0.000366	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—pancreatic cancer	6.11e-05	0.000365	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—pancreatic cancer	6.08e-05	0.000364	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—pancreatic cancer	6.08e-05	0.000364	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—pancreatic cancer	6.08e-05	0.000364	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—pancreatic cancer	6.06e-05	0.000363	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—pancreatic cancer	6.01e-05	0.000359	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—pancreatic cancer	5.95e-05	0.000356	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—pancreatic cancer	5.92e-05	0.000354	CcSEcCtD
Tamoxifen—Diarrhoea—Docetaxel—pancreatic cancer	5.91e-05	0.000354	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—pancreatic cancer	5.83e-05	0.000349	CcSEcCtD
Tamoxifen—Infection—Epirubicin—pancreatic cancer	5.79e-05	0.000346	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—pancreatic cancer	5.77e-05	0.000345	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—pancreatic cancer	5.72e-05	0.000342	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—pancreatic cancer	5.71e-05	0.000341	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—pancreatic cancer	5.71e-05	0.000341	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—pancreatic cancer	5.64e-05	0.000337	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—pancreatic cancer	5.63e-05	0.000337	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—pancreatic cancer	5.63e-05	0.000337	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—pancreatic cancer	5.63e-05	0.000337	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—pancreatic cancer	5.61e-05	0.000335	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—pancreatic cancer	5.56e-05	0.000333	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—pancreatic cancer	5.56e-05	0.000332	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—pancreatic cancer	5.5e-05	0.000329	CcSEcCtD
Tamoxifen—Vomiting—Docetaxel—pancreatic cancer	5.5e-05	0.000329	CcSEcCtD
Tamoxifen—Rash—Docetaxel—pancreatic cancer	5.45e-05	0.000326	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—pancreatic cancer	5.44e-05	0.000326	CcSEcCtD
Tamoxifen—Headache—Docetaxel—pancreatic cancer	5.41e-05	0.000324	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—pancreatic cancer	5.39e-05	0.000323	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—pancreatic cancer	5.36e-05	0.000321	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.31e-05	0.000318	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.28e-05	0.000316	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—pancreatic cancer	5.27e-05	0.000315	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—pancreatic cancer	5.24e-05	0.000313	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.21e-05	0.000312	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—pancreatic cancer	5.2e-05	0.000311	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—pancreatic cancer	5.14e-05	0.000308	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—pancreatic cancer	5.13e-05	0.000307	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—pancreatic cancer	5.13e-05	0.000307	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—pancreatic cancer	5.07e-05	0.000303	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.03e-05	0.000301	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—pancreatic cancer	5.03e-05	0.000301	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—pancreatic cancer	4.99e-05	0.000298	CcSEcCtD
Tamoxifen—Pain—Epirubicin—pancreatic cancer	4.99e-05	0.000298	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.91e-05	0.000294	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—pancreatic cancer	4.88e-05	0.000292	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—pancreatic cancer	4.84e-05	0.00029	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—pancreatic cancer	4.81e-05	0.000288	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.77e-05	0.000285	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—pancreatic cancer	4.75e-05	0.000284	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—pancreatic cancer	4.69e-05	0.000281	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.66e-05	0.000279	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—pancreatic cancer	4.65e-05	0.000278	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—pancreatic cancer	4.63e-05	0.000277	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—pancreatic cancer	4.61e-05	0.000276	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—pancreatic cancer	4.61e-05	0.000276	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—pancreatic cancer	4.61e-05	0.000276	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.41e-05	0.000264	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—pancreatic cancer	4.3e-05	0.000257	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—pancreatic cancer	4.29e-05	0.000256	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—pancreatic cancer	4.26e-05	0.000255	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—pancreatic cancer	4.18e-05	0.00025	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—pancreatic cancer	4.12e-05	0.000247	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—pancreatic cancer	3.99e-05	0.000239	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—pancreatic cancer	3.97e-05	0.000238	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—pancreatic cancer	3.87e-05	0.000232	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—pancreatic cancer	3.86e-05	0.000231	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—pancreatic cancer	3.82e-05	0.000228	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—pancreatic cancer	3.71e-05	0.000222	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—pancreatic cancer	3.69e-05	0.000221	CcSEcCtD
Tamoxifen—Rash—Epirubicin—pancreatic cancer	3.68e-05	0.00022	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—pancreatic cancer	3.67e-05	0.00022	CcSEcCtD
Tamoxifen—Headache—Epirubicin—pancreatic cancer	3.65e-05	0.000218	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—pancreatic cancer	3.57e-05	0.000213	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—pancreatic cancer	3.46e-05	0.000207	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—pancreatic cancer	3.43e-05	0.000205	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—pancreatic cancer	3.4e-05	0.000203	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—pancreatic cancer	3.4e-05	0.000203	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—pancreatic cancer	3.38e-05	0.000202	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—pancreatic cancer	3.2e-05	0.000192	CcSEcCtD
Tamoxifen—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	6.29e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GCG—pancreatic cancer	6.29e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—STK11—pancreatic cancer	6.27e-06	0.000104	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—STK11—pancreatic cancer	6.26e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.25e-06	0.000103	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.12e-06	0.000101	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—APOE—pancreatic cancer	6.11e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PPARG—pancreatic cancer	6.07e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CG—pancreatic cancer	6.06e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—APOE—pancreatic cancer	6.05e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.03e-06	9.98e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.03e-06	9.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CD44—pancreatic cancer	6.01e-06	9.94e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.92e-06	9.79e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—STK11—pancreatic cancer	5.91e-06	9.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.89e-06	9.73e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PPARG—pancreatic cancer	5.85e-06	9.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.83e-06	9.64e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GLP1R—pancreatic cancer	5.78e-06	9.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GCG—pancreatic cancer	5.76e-06	9.53e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—DPYD—pancreatic cancer	5.69e-06	9.41e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TERT—pancreatic cancer	5.59e-06	9.25e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—APOE—pancreatic cancer	5.55e-06	9.18e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.55e-06	9.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.54e-06	9.16e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	5.53e-06	9.15e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTEN—pancreatic cancer	5.52e-06	9.13e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CG—pancreatic cancer	5.51e-06	9.12e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—TYMS—pancreatic cancer	5.51e-06	9.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.5e-06	9.09e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—pancreatic cancer	5.48e-06	9.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	5.46e-06	9.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—STK11—pancreatic cancer	5.42e-06	8.96e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	5.4e-06	8.93e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—TYMS—pancreatic cancer	5.39e-06	8.92e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—TYMS—pancreatic cancer	5.38e-06	8.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CD44—pancreatic cancer	5.37e-06	8.87e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	5.35e-06	8.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.34e-06	8.84e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TSC2—pancreatic cancer	5.33e-06	8.82e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CD—pancreatic cancer	5.33e-06	8.81e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—pancreatic cancer	5.32e-06	8.8e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CA—pancreatic cancer	5.28e-06	8.74e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—pancreatic cancer	5.27e-06	8.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.25e-06	8.69e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CD44—pancreatic cancer	5.24e-06	8.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APOE—pancreatic cancer	5.22e-06	8.63e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.21e-06	8.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.16e-06	8.53e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—pancreatic cancer	5.15e-06	8.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GCG—pancreatic cancer	5.14e-06	8.51e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—pancreatic cancer	5.11e-06	8.46e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.09e-06	8.41e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—TYMS—pancreatic cancer	5.08e-06	8.41e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GCG—pancreatic cancer	5.02e-06	8.3e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	5.01e-06	8.28e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD44—pancreatic cancer	4.94e-06	8.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD44—pancreatic cancer	4.89e-06	8.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	4.86e-06	8.04e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CD—pancreatic cancer	4.85e-06	8.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—STK11—pancreatic cancer	4.84e-06	8e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—pancreatic cancer	4.83e-06	7.99e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	4.82e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	4.82e-06	7.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	4.8e-06	7.94e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.79e-06	7.92e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—pancreatic cancer	4.78e-06	7.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.75e-06	7.85e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GCG—pancreatic cancer	4.73e-06	7.82e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—STK11—pancreatic cancer	4.72e-06	7.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	4.71e-06	7.79e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.7e-06	7.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GCG—pancreatic cancer	4.69e-06	7.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.66e-06	7.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGF—pancreatic cancer	4.66e-06	7.7e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CB—pancreatic cancer	4.64e-06	7.68e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—pancreatic cancer	4.6e-06	7.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.54e-06	7.51e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—APOE—pancreatic cancer	4.48e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.46e-06	7.38e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—STK11—pancreatic cancer	4.45e-06	7.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—STK11—pancreatic cancer	4.41e-06	7.29e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	4.4e-06	7.28e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.39e-06	7.26e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—APOE—pancreatic cancer	4.39e-06	7.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—APOE—pancreatic cancer	4.38e-06	7.24e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—pancreatic cancer	4.32e-06	7.14e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CB—pancreatic cancer	4.22e-06	6.99e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	4.19e-06	6.92e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—pancreatic cancer	4.19e-06	6.92e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD44—pancreatic cancer	4.18e-06	6.91e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.17e-06	6.89e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—pancreatic cancer	4.17e-06	6.89e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.16e-06	6.88e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—pancreatic cancer	4.15e-06	6.86e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	4.14e-06	6.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.14e-06	6.85e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—APOE—pancreatic cancer	4.13e-06	6.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.09e-06	6.77e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—TYMS—pancreatic cancer	4.06e-06	6.72e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.06e-06	6.71e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	4.04e-06	6.68e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—pancreatic cancer	4.01e-06	6.63e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GCG—pancreatic cancer	4.01e-06	6.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—pancreatic cancer	3.99e-06	6.59e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	3.96e-06	6.55e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.95e-06	6.53e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.91e-06	6.47e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—pancreatic cancer	3.9e-06	6.45e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—pancreatic cancer	3.9e-06	6.44e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	3.84e-06	6.35e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.83e-06	6.33e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—pancreatic cancer	3.82e-06	6.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.81e-06	6.3e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—pancreatic cancer	3.8e-06	6.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.79e-06	6.27e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—APOE—pancreatic cancer	3.79e-06	6.27e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—STK11—pancreatic cancer	3.77e-06	6.23e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	3.73e-06	6.17e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—pancreatic cancer	3.65e-06	6.04e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—pancreatic cancer	3.62e-06	5.98e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	3.61e-06	5.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—pancreatic cancer	3.6e-06	5.96e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.59e-06	5.93e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	3.55e-06	5.87e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.54e-06	5.85e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	3.48e-06	5.75e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.47e-06	5.74e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	3.47e-06	5.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.42e-06	5.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—APOE—pancreatic cancer	3.38e-06	5.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—pancreatic cancer	3.32e-06	5.49e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—pancreatic cancer	3.32e-06	5.48e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—APOE—pancreatic cancer	3.3e-06	5.46e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.3e-06	5.46e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	3.28e-06	5.42e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.24e-06	5.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—pancreatic cancer	3.23e-06	5.34e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD44—pancreatic cancer	3.23e-06	5.34e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.2e-06	5.3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	3.2e-06	5.29e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—pancreatic cancer	3.18e-06	5.26e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—pancreatic cancer	3.14e-06	5.19e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—pancreatic cancer	3.12e-06	5.16e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—APOE—pancreatic cancer	3.11e-06	5.15e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	3.1e-06	5.12e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCG—pancreatic cancer	3.09e-06	5.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—APOE—pancreatic cancer	3.09e-06	5.1e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—pancreatic cancer	3.07e-06	5.07e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.05e-06	5.05e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	3.03e-06	5.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.03e-06	5e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	3.01e-06	4.97e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—pancreatic cancer	3.01e-06	4.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3e-06	4.96e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.98e-06	4.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.95e-06	4.87e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	2.94e-06	4.86e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.92e-06	4.83e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—STK11—pancreatic cancer	2.91e-06	4.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—pancreatic cancer	2.89e-06	4.78e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—pancreatic cancer	2.88e-06	4.76e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	2.86e-06	4.73e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—pancreatic cancer	2.83e-06	4.69e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—pancreatic cancer	2.83e-06	4.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	2.82e-06	4.66e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.81e-06	4.64e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—pancreatic cancer	2.79e-06	4.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.78e-06	4.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—pancreatic cancer	2.78e-06	4.6e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—pancreatic cancer	2.76e-06	4.57e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.71e-06	4.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.69e-06	4.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.68e-06	4.44e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—pancreatic cancer	2.68e-06	4.42e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APOE—pancreatic cancer	2.64e-06	4.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.62e-06	4.34e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.62e-06	4.33e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.62e-06	4.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.62e-06	4.32e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.6e-06	4.3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—pancreatic cancer	2.59e-06	4.29e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	2.59e-06	4.28e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—pancreatic cancer	2.58e-06	4.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	2.55e-06	4.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—pancreatic cancer	2.54e-06	4.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.5e-06	4.14e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.5e-06	4.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—pancreatic cancer	2.47e-06	4.09e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.47e-06	4.08e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.45e-06	4.05e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—pancreatic cancer	2.4e-06	3.97e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—pancreatic cancer	2.39e-06	3.96e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.38e-06	3.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.34e-06	3.87e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.34e-06	3.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.32e-06	3.83e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—pancreatic cancer	2.31e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.3e-06	3.8e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.28e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.27e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.26e-06	3.74e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	2.2e-06	3.64e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.15e-06	3.56e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.13e-06	3.53e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.13e-06	3.53e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—pancreatic cancer	2.13e-06	3.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.11e-06	3.5e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—pancreatic cancer	2.1e-06	3.48e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.09e-06	3.46e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.09e-06	3.45e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—pancreatic cancer	2.04e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APOE—pancreatic cancer	2.03e-06	3.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.02e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—pancreatic cancer	1.97e-06	3.26e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—pancreatic cancer	1.91e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	3.12e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.86e-06	3.08e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.85e-06	3.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.84e-06	3.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.84e-06	3.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.84e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.82e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.81e-06	2.99e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—pancreatic cancer	1.8e-06	2.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.77e-06	2.93e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	1.74e-06	2.88e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.61e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.6e-06	2.64e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.58e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.54e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.51e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.51e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.43e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.42e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.41e-06	2.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.39e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.39e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.31e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.31e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.3e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.22e-06	2.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.17e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—pancreatic cancer	1.14e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.11e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.07e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.06e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—pancreatic cancer	9.08e-07	1.5e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.58e-07	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.01e-07	1.16e-05	CbGpPWpGaD
